CryoPort, Inc. short interest in 2024
In 2024, CryoPort, Inc.'s disclosed short interest ran from 8.05% of shares outstanding on 12 Jan 2024 to 4.20% on 31 Dec 2024, a change of -3.85 percentage points. The year's high was 9.05% on 15 Apr 2024 and its low 4.20% on 31 Dec 2024, averaging 6.94% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.37 days on 15 Feb 2024. Full history: CryoPort, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 8.05% (12 Jan 2024)
- End of year
- 4.20% (31 Dec 2024)
- Change
- -3.85 pp
- High
- 9.05% (15 Apr 2024)
- Low
- 4.20% (31 Dec 2024)
- Average
- 6.94%
- Highest days to cover
- 12.37 (15 Feb 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 8.05% | 7.53 | |
| 31 Jan 2024 | 8.78% | 11.95 | |
| 15 Feb 2024 | 8.60% | 12.37 | |
| 29 Feb 2024 | 7.99% | 12.24 | |
| 15 Mar 2024 | 8.52% | 7.13 | results (8-K), 10-K filed |
| 28 Mar 2024 | 8.29% | 6.29 | |
| 15 Apr 2024 | 9.05% | 11.23 | |
| 30 Apr 2024 | 8.53% | 11.74 | |
| 15 May 2024 | 8.26% | 6.95 | results (8-K), 10-Q filed |
| 31 May 2024 | 8.04% | 9.93 | |
| 14 Jun 2024 | 7.41% | 4.71 | |
| 28 Jun 2024 | 6.45% | 2.85 | |
| 15 Jul 2024 | 7.30% | 3.42 | |
| 31 Jul 2024 | 6.80% | 4.10 | |
| 15 Aug 2024 | 6.50% | 3.10 | results (8-K), 10-Q filed |
| 30 Aug 2024 | 6.03% | 5.65 | |
| 13 Sep 2024 | 5.89% | 7.14 | |
| 30 Sep 2024 | 5.33% | 6.10 | |
| 15 Oct 2024 | 5.70% | 6.20 | |
| 31 Oct 2024 | 5.88% | 10.35 | |
| 15 Nov 2024 | 5.46% | 5.52 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 5.06% | 4.43 | |
| 13 Dec 2024 | 4.45% | 5.42 | |
| 31 Dec 2024 | 4.20% | 8.30 |
See also: CryoPort, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.